More importantly, these findings indicate that CAE positively affected the peripheral levels of metabolically beneficial NAEs without changing those of CB1-activating, and hence potentially obesity-exacerbating, endocannabinoids, i.e., AEA and 2-AG. The gene discussed is CNR1; the disease is Obesity.